Are you an adult aged 50 or older and HAVE NOT RECEIVED A PNEUMOCOCCAL VACCINE?

Consider the STRIDE-10 clinical research study

Pneumococcal disease is an illness caused by certain germs (bacteria) called Streptococcus pneumoniae. These germs can cause serious infections in the ears, nose, lungs, blood or brain.


Vaccines help the body fight infections due to diseases like pneumococcal disease, and may help prevent serious illness. New vaccines must be tested to show that they work.

The STRIDE-10 study is testing an investigational study vaccine (V116) to see if it can help protect against pneumococcal disease. This study is testing V116 in adults who have not previously received any pneumococcal vaccine and will compare V116 to Pneumovax23® (pneumococcal 23-valent vaccine).


Pneumovax23® is approved for preventing pneumococcal disease in some countries, but may not be approved in your country.


This study will evaluate the safety of V116 and see how well the vaccine works and how your body responds to it.

You may be eligible for this study if you are aged 50 or older and:

  • Have not previously received any pneumococcal vaccine.
  • Have not had a positive test (culture) for pneumococcal disease within the last 3 years.
  • If you are a female able to have children, you are not currently pregnant or breastfeeding, and agree not to Breastfeed or become pregnant for at least 6 weeks after receiving the study vaccination.
  • Additional requirements apply.

The study vaccines and study-related tests will be provided at no cost.

You may also be reimbursed for study travel and related expenses. For more information, including the possible risks and benefits of participation, please contact us.

Armida Balawon: | 02078825669

Francis Galera: | 02078825705

STRIDE-10 Study Prescreener

The following questions apply to the person interested in participating in the trial.